Home > Global news > ‘Super breed’ of medicinal cannabis developed by British drug firm

‘Super breed’ of medicinal cannabis developed by British drug firm

A BRITISH pharmaceutical company was working today to develop a new breed of cannabis-based products aimed at treating a range of conditions including diabetes, epilepsy and Crohn’s disease.

GW Pharmaceuticals, which launched a cannabis-derived medicine for symptoms of multiple sclerosis last year, has cross-bred different types of the plant to produce a new strain that could treat a wide range of disorders.

The new varieties contain enhanced levels of therapeutic compounds, including an appetite suppressant cannabinoid called THCV, which the company hopes will be used in the treatment of type 2 diabetes, obesity and other metabolic disorders.

Research leader Dr. David Potter said, “We’ve demonstrated that there are something like 60 cannabinoids in the cannabis plant, and so far we’ve looked in detail only at 12 to 15. You could say we’ve only scratched the surface so far.”


Categories: Global news
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: